
VHL Antibody (G-3) is a mouse monoclonal IgM antibody that detects von Hippel-Lindau (VHL) in mouse samples through various applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). VHL plays a crucial role as a tumor suppressor, and VHL function is vital in regulating cellular responses to hypoxia by targeting hypoxia-inducible factors (HIFs) for degradation. This regulation is essential because HIFs are key transcription factors that promote the expression of genes involved in angiogenesis, metabolism, and cell survival under low oxygen conditions. Dysregulation of VHL can lead to HIF accumulation, resulting in uncontrolled cell growth and tumorigenesis, particularly in renal carcinoma and other associated tumors. VHL interacts with the Elongin (SIII) complex, composed of Elongin A, Elongin B, and Elongin C, thereby inhibiting transcriptional activity and maintaining cellular homeostasis. Different isoforms of VHL, encoded by alternatively spliced transcript variants, add complexity to VHL function and regulation, with variations in molecular weight observed across species. Anti-VHL antibody (G-3) is an invaluable tool for researchers studying tumor suppression mechanisms and molecular pathways involved in cancer development.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Von Hippel Lindau/VHL Antibody (G-3) | sc-514041 | 200 µg/ml | $322.00 | |||
Von Hippel Lindau/VHL Antibody (G-3): m-IgGκ BP-HRP Bundle | sc-524582 | 200 µg Ab, 40 µg BP | $361.00 | |||
Von Hippel Lindau/VHL (G-3) Neutralizing Peptide | sc-514041 P | 100 µg/0.5 ml | $69.00 |